A CDDY result frightens more Toy and Miniature Poodle breeders than almost any other line on a DNA panel. The dog is healthy. The dog's parents were healthy. And the report says something about intervertebral disc disease.
Two things are true at once here, and holding both is the whole point of this article. The risk is real. And the response most breeders reach for would do more damage to the breed than the variant does.
First: CDDY is not CDPA
This is the single most common error made with these two tests, and everything downstream depends on getting it right.
There are two separate FGF4 retrogenes in dogs. A retrogene is a copy of a gene that has been reinserted somewhere else in the genome, and where it lands changes what it does.
CDPA sits on chromosome 18. It is the retrogene behind the classic short-legged outline, and it is breed-defining in dogs like the Dachshund and the Corgi. It is not established as the primary IVDD-risk retrogene. It does turn up on poodle reports, and no poodle-specific frequency has been published for it, so treat it as a result to understand rather than one to predict.
CDDY sits on chromosome 12. This is the one associated with disc disease. It acts on the intervertebral discs, causing them to degenerate and mineralise earlier than they otherwise would.
A warning about how CDDY is often described. The literature groups CDDY under "chondrodystrophy," a word that suggests shortened legs. In a poodle that framing is actively misleading. CDDY is not a meaningful leg-shortening gene in this breed, and you cannot judge a dog's CDDY status by looking at it. A normally proportioned poodle with correct leg length can carry two copies. If you take away one practical point from this section, make it that one: the only way to know is to test.
If your report shows CDPA and you have been worrying about your dog's back, you have been worrying about the wrong test. If it shows CDDY, read on.
A note on wording: it would be convenient to say CDPA has no relationship to disc disease at all. That is not quite what the evidence supports. Breeds carrying CDPA alone show a low clinical incidence of disc calcification and a correspondingly lower prevalence of IVDD, not an absence of it. The accurate statement is that CFA18 is not established as the primary IVDD-risk retrogene. A CDPA result should not be read as an IVDD risk result.
What CDDY actually does
CDDY is not a recessive, and this trips up breeders who have learned to think in carrier-and-clear terms.
For most of the health tests on a poodle panel, one copy is harmless. The dog is a carrier, it will never develop the condition, and the only thing that matters is who you breed it to. CDDY does not work that way. A single copy carries elevated risk, and two copies carry more. It behaves with a dose effect.
So "carrier" is the wrong mental model. The right one is: this is a risk factor that comes in strengths.
What it does mechanically is accelerate the degeneration of the intervertebral discs. Discs that would normally stay supple for years become mineralised and brittle earlier. A brittle disc is more likely to herniate, and a herniated disc pressing on the spinal cord is what an IVDD episode is.
But a risk factor is not a diagnosis. Plenty of dogs carry CDDY and never have a disc episode in their lives. The genotype tells you about probability across a population. It does not tell you what will happen to the dog in front of you.
The number you have probably seen, and why we do not print it
If you have researched CDDY in poodles, you have almost certainly encountered figures along the lines of "57 per cent of Toy Poodles" and "61 per cent of Miniature Poodles."
We traced those figures. They originate in a breeder-facing article that itself describes the data as coming from a small sample tested at the University of California, Davis. No sample size has been published. No geographic origin. No ascertainment method, which is to say no account of how those dogs came to be tested in the first place, and dogs tested at a veterinary genetics laboratory are not a random sample of the breed. No confidence interval.
That is not a population frequency. It is a number that escaped into circulation and has been repeated ever since.
So we do not reproduce it, and neither should anyone else. Here is what can be said instead, with sources behind it:
- Across dog breeds generally, the CFA12 retrogene allele frequency ranges from 0.02 to 1.0 depending on the breed (Batcher et al., 2019). In some breeds it is entirely absent. In others it is fixed, meaning every single dog carries two copies.
- The poodle varieties segregate for it, meaning it is present in some dogs and absent in others rather than fixed across the breed. It is reported more often in the Toy and Miniature. That does not make the Standard Poodle exempt. Standards do carry it, and a Standard breeder who skips the test on the assumption that it is a small-variety problem is making an assumption the evidence does not support.
- No peer-reviewed poodle-specific frequency has been published.
The practical instruction survives without the percentage: the variant is common enough in the small varieties that every breeding animal is worth testing. That is the actionable point, and it does not depend on a number nobody can verify.
Why culling would be a catastrophe
Here is the reasoning that matters most.
Suppose the circulating figures are roughly right and something over half of Toy and Miniature Poodles carry at least one copy. Now suppose the breed responded the way panicked breeders often do, and removed every CDDY-positive dog from breeding.
You would have removed more than half the gene pool in a single generation.
Not half the affected dogs. Not half the high-risk dogs. Half the dogs, along with every other gene each of them carried: their structure, their temperament, their longevity, their resistance to everything else, and all the rare alleles that exist in a small population precisely because a few individuals happen to hold them.
And you would have done it to reduce an IVDD burden that has never been quantified in poodles. There is no published poodle incidence study. Nobody knows how many poodles actually experience clinical disc disease attributable to this variant.
That is the trade on offer: a certain, immediate, irreversible collapse in genetic diversity, in exchange for an unmeasured reduction in an unmeasured problem.
It is a bad trade. It would also not be the first time a breed made it. The history of dog breeding is substantially a history of eliminating one problem and discovering, two generations later, what else went out with it.
What to do instead
Test, and know where you stand. Not so you can exclude dogs, but so you can make informed pairings and give buyers accurate information.
Do not double down without reason. If both parents carry two copies, every puppy gets two copies. Where you have a choice between two otherwise comparable mates, choosing the one that lowers the dose is free. Where you do not have that choice, this is one consideration among many, and it does not outrank structure, temperament, or diversity.
Understand that clear is not always available. In a population where a variant is this common, insisting on clear mates can force you into a much smaller pool of dogs, which concentrates everything else. Sometimes the CDDY-positive pairing is the better breeding decision overall. That is a legitimate conclusion, not a compromise.
Manage the environment, because it is not all genetic. Disc disease risk responds to body condition and mechanical loading. A lean dog is doing its spine a considerable favour. Discouraging repeated jumping down from furniture, using ramps where practical, and keeping weight off are all interventions available to every owner regardless of genotype. A CDDY-positive dog in lean condition may well be at lower practical risk than a CDDY-clear dog carrying four extra pounds.
Disclose. Tell buyers what the dog carries and what it means, including the honest statement that the magnitude of risk in poodles is not established. Breeders who disclose build the kind of reputation that survives a bad outcome. Breeders who conceal do not.
The bottom line
CDDY is a genuine risk factor for intervertebral disc disease, established in the peer-reviewed literature. It is common in Toy and Miniature Poodles. Its clinical burden in this breed has never been measured.
Testing is worthwhile. Panic is not. Culling would be actively harmful.
This is the argument of the whole volume in miniature: a real finding, an unquantified magnitude, and a breed-level response that must be weighed against what it costs. The instinct to eliminate a variant feels like responsible breeding. Very often it is the opposite.
This article summarises material developed at length in Chapter 17 of Poodle Health & Structural Genetics: The Science Behind Form, Function and Disease (Volume III of the Poodle Genetics series). It is educational and is not veterinary advice. Discuss breeding and clinical decisions with your veterinarian.
Built on identified genes and validated tests. The claims here are supported by the peer-reviewed literature listed below.
- Published
- July 21, 2026
- Last reviewed
- July 21, 2026
References
- Brown EA, Dickinson PJ, Mansour T, et al. (2017). FGF4 retrogene on CFA12 is responsible for chondrodystrophy and intervertebral disc disease in dogs. Proceedings of the National Academy of Sciences USA 114(43): 11476–11481. doi:10.1073/pnas.1709082114
- Batcher K, Dickinson P, Giuffrida M, et al. (2019). Phenotypic effects of FGF4 retrogenes on intervertebral disc disease in dogs. Genes 10(6): 435. doi:10.3390/genes10060435
- Parker HG, VonHoldt BM, Quignon P, et al. (2009). An expressed Fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogs. Science 325(5943): 995–998. doi:10.1126/science.1173275
Free Tool
Apply This Knowledge
Model any parent pair with our interactive genetics calculator.